...

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >LONG-TERM FOLLOW-UP OF RANIBIZUMAB TREATED PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION FROM THE RADIANCE CLINICAL TRIAL IN FOUR EAST ASIAN COUNTRIES

【24h】

LONG-TERM FOLLOW-UP OF RANIBIZUMAB TREATED PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION FROM THE RADIANCE CLINICAL TRIAL IN FOUR EAST ASIAN COUNTRIES

机译：从东亚四个国家的放射线临床试验对Ranibizumab治疗的患有肌性脉络膜新发神经丝虫病的患者进行的长期随访

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第7期|共1页
作者
Skelly A.; Lara N.; Pedros M.; Macfadden W.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. LONG-TERM FOLLOW-UP OF RANIBIZUMAB TREATED PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION FROM THE RADIANCE CLINICAL TRIAL IN FOUR EAST ASIAN COUNTRIES [J] . Skelly A., Lara N., Pedros M., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：从东亚四个国家的放射线临床试验对Ranibizumab治疗的患有肌性脉络膜新发神经丝虫病的患者进行的长期随访
2. Long-term outcomes in ranibizumab-treated East Asian patients with myopic choroidal neovascularization in the 36-month post-RADIANCE study period [J] . Wieland Mark, Day Bann-mo, Eccoffier Tatiana, Investigative ophthalmology & visual science . 2018,第9期

机译：Ranibizumab治疗的东亚患者的长期成果在36个月后36个月后的近视脉络膜新生血管形成
3. LONG-TERM OUTCOMES OF RANIBIZUMAB TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION IN EAST-ASIAN PATIENTS FROM THE RADIANCE STUDY [J] . Tan Nikolle W., Ohno-Matsui Kyoko, Koh Hyoung J., Retina . 2018,第11期

机译：辐射研究中东亚患者近视脉络膜新血管形成的长期结果
4. Long-term clinical evaluation of endodontically treated teeth by 15 F CO2 laser microprobe: three years clinical follow-up of 1512 root canals--in-vivo study [C] . Gavriel Kesler, Dental Clinic Ctr., Petach Tiyva, Conference on lasers in dentistry . 1999

机译：15 F CO2激光微探针对牙髓治疗牙齿的长期临床评估：1512根管的三年临床随访-体内研究
5. Clinical Features of Treated and Untreated Type 1 Idiopathic Macular Telangiectasia Without the Occurrence of Secondary Choroidal Neovascularization Followed for 2 Years in Japanese Patients [D] . 逢坂理恵 2019

机译：在日本患者中治疗和未治疗的1型特发性黄斑部毛细血管扩张症的临床特征为继发性脉络膜新血管形成，随访2年
6. LONG-TERM OUTCOMES OF RANIBIZUMAB TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION IN EAST-ASIAN PATIENTS FROM THE RADIANCE STUDY [O] . Nikolle W. Tan, Kyoko Ohno-Matsui, Hyoung J. Koh, -1

机译：从放射学研究看东亚兰尼单抗治疗肌性脉络膜新生血管的长期结果
7. Long-Term Follow-Up of Ranibizumab Treated Patients with Myopic Choroidal Neovascularization from the Radiance Clinical Trial in Four East Asian Countries [O] . A Skelly, N Lara, M Pedros, 2016

机译：Ranibizumab对四个东亚国家的辐射临床试验中近视脉络膜新生血管化患者的长期随访
8. Macular Photocoagulation Study: Data Collection Forms for Randomized Trials ofSubfoveal Choroidal Neovascularization. (Forms Completed at Clinical Centers) [R] . 1991

机译：黄斑光凝术研究：中心凹脉络膜新生血管随机试验的数据收集形式。（临床中心完成的表格）

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号